Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes in Both GnRH Agonist and GnRH Antagonist Treated Ovarian Stimulation Protocols

NCT02114645 is registered in ClinicalTrials.gov with Zekai Tahir Burak Women's Health Research and Education Hospital as lead sponsor.

NCT NCT02114645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02114645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes in Both GnRH Agonist and GnRH Antagonist Treated Ovarian Stimulation Protocols
Lead sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2014
Completion date
April 30, 2015
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility